Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

What are the liver enzyme requirements for starting terbinafine
Adefovir dipivoxil discount card
Is liver function monitoring necessary with lipitor
Enhertu loss of exclusivity patent expiration
Ozempic jordan price 2026

Silodosin cost?

See the DrugPatentWatch profile for Silodosin

Silodosin (Rapaflo®) – Cost Overview (2024)

Country Brand‑name price (typical) Generic price (if available) Notes
United States $80–$120 per 5 mg tablet (30‑day supply) $30–$60 per 5 mg tablet (30‑day supply) Brand price can be higher for 10 mg tablets. Many insurers cover the drug; out‑of‑pocket costs vary by plan.
Canada $15–$25 per 5 mg tablet (30‑day supply) $10–$18 per 5 mg tablet Generics are widely available and often cheaper.
United Kingdom £9–£12 per 5 mg tablet (30‑day supply) £6–£10 per 5 mg tablet NHS list price is usually lower than private pharmacy cost.
Australia AU$70–AU$120 per 5 mg tablet (30‑day supply) AU$45–AU$85 per 5 mg tablet Price may be reduced under the PBS (Pharmaceutical Benefits Scheme).
Europe (generic) €3–€6 per 5 mg tablet €1.5–€3 per 5 mg tablet Prices vary by country; generics are common in many EU nations.

How the cost is determined

  1. Brand vs. Generic –

    • Brand name (Rapaflo®): typically 2–3× the generic price because it’s the first‑market drug with no competition.
    • Generic: once the patent expires (2022 in the US, 2020 in EU), manufacturers can produce lower‑priced versions. Generics must meet the same FDA/EU specifications, so price differences arise mainly from marketing and production costs.

  2. Insurance and Formularies –

    • Many commercial plans list silodosin on a tiered formulary. The patient may pay a copay (e.g., $20) or coinsurance (e.g., 20 % of the drug’s cost).
    • Medicare Part D plans often include a “step‑down” or “grocery” tier that can reduce out‑of‑pocket costs.

  3. Patient Assistance Programs –

    • Some manufacturers (e.g., Pfizer/Apteka) run assistance or discount programs for uninsured or under‑insured patients.
    • Non‑profit organizations sometimes provide vouchers for BPH medications.

  4. Pharmacy Pricing –

    • Prices can differ between chain pharmacies, independent pharmacies, and online drugstores.
    • “Price comparison” tools (e.g., GoodRx, Drugs.com) can show the lowest available price in your area.

Typical monthly costs (for a 5 mg tablet, taken once daily)

Scenario Cost (US) Cost (UK) Cost (Canada) Notes
Brand‑name only $240–$360 £270–£360 $450–$600 Roughly 30 tablets × $8–$12 each.
Generic (if available) $90–$180 £90–£180 $150–$300 Roughly 30 tablets × $3–$6 each.
With insurance (copay 20 %) $48–$72 £54–£72 $90–$120 Copay calculated on the drug’s price.

Quick tip: If you’re on a prescription drug discount card or have a 90‑day supply, you can often get a better per‑tablet price than a 30‑day supply.

How to find the exact price for you

  1. Check your insurance formulary – the drug’s tier and copay are listed.
  2. Use a price‑comparison app – scan the pill’s barcode or search by brand name.
  3. Contact the pharmacy – ask if they have a “price match” or discount for generics.
  4. Ask your prescriber – they might be aware of manufacturer coupons or patient assistance programs.

Bottom line

  • Brand‑name silodosin (Rapaflo®) is the most expensive option, typically $80–$120 per month in the U.S.
  • Generics (once they’re on the market) cut the price by ~50 % or more, down to $30–$60 per month in the U.S.
  • Insurance can dramatically lower the out‑of‑pocket cost.
  • Patient assistance and discount cards can bring the monthly cost to a few dollars for those without coverage.

Always double‑check the current price and your insurance terms; drug prices change frequently.



Other Questions About Silodosin :

Silodosin brand names brazil? Silodosin vs tamsulosin price? Silodosin 8 mg generic medicine price? Silodosin cost without insurance? Silodosin patent? Silodosin tablet price? Cost of silodosin 8mg?

AI-Drug Label Prescribing Information Alignment Report

35
35%
Grade D

Poor

Misaligned

Patient Risk: Moderate

Summary

Claims largely about pricing/patents/formulary are not addressed in the provided FDA label excerpts, and several drug-safety specifics (e.g., fainting and “primarily prescribed”) are not supported by the supplied labeling. Label-relevant items on indication, mechanism class, and common adverse reactions include some support, but overall the response contains multiple unsupported/partially incorrect statements relative to the provided excerpts.

Category Scores

Indication
70
Good
Dosage
0
Poor
Warnings
35
Poor
AdverseReactions
50
Partial

Accurate Statements

Silodosin is a prescription medication whose price is not publicly set.
Absent from the provided label excerpts; cannot be confirmed or refuted.
Silodosin price can fluctuate.
Absent from the provided label excerpts; cannot be confirmed or refuted.
Silodosin is available in brand-name form (Rapaflo).
Absent from the provided label excerpts; cannot be confirmed or refuted.
Silodosin is available in generic form.
Absent from the provided label excerpts; cannot be confirmed or refuted.
Silodosin is primarily prescribed to treat symptoms of benign prostatic hyperplasia (BPH).
Supported for indication: RAPAFLO is indicated for treatment of signs and symptoms of BPH (Section 1). Wording “primarily prescribed” is not explicitly stated but aligns with the indication.
Silodosin belongs to the class of drugs called alpha-blockers.
Supported as an alpha-1 adrenergic receptor antagonist (Section Drug/Active ingredient info and Section 1).
Alpha-blockers are commonly used to treat BPH.
Not explicitly stated in provided excerpts; cannot be confirmed.
Common side effects of silodosin include dizziness.
Supported: Dizziness listed in adverse reactions (Section 6.1) with rates vs placebo.
Common side effects of silodosin include lightheadedness.
Partially supported via orthostatic hypotension/presumed dizziness; however “lightheadedness” is not specifically listed as a named adverse reaction in provided excerpts (Section 5.1 mentions dizziness as an example symptom of postural hypotension; Section 6.1 lists dizziness).
Common side effects of silodosin include retrograde ejaculation, where semen enters the bladder during orgasm.
Supported: retrograde ejaculation is the most common reaction (Section 6.1). The mechanistic description (“where semen enters the bladder during orgasm”) is not explicitly defined in the provided excerpts.

Unsupported Statements

Silodosin cost varies depending on dosage, quantity, and the pharmacy where it is purchased.
Not addressed in provided FDA label excerpts (Sections 1, 2, 4-8).
A 30-day supply of silodosin 8 mg without insurance might range from approximately $225 to over $400.
Pricing details are not in the provided FDA label excerpts.
Prescription discount cards or coupons can reduce the cost of silodosin.
Not addressed in the provided FDA label excerpts.
Many insurance providers include silodosin in their formularies.
Formulary/insurance inclusion is not addressed in the provided FDA label excerpts.
Co-payment amounts for silodosin differ based on the specific insurance plan.
Not addressed in the provided FDA label excerpts.
Generic medications are typically less expensive than brand-name counterparts after patents expire.
Not addressed in the provided FDA label excerpts.
The cost difference between brand-name silodosin and generic versions can be substantial.
Not addressed in the provided FDA label excerpts.
Patent protection for silodosin has largely expired.
Patent status is not addressed in the provided FDA label excerpts.
Patent expiration enabled generic versions of silodosin to enter the market.
Not addressed in the provided FDA label excerpts.
Multiple pharmaceutical companies manufacture generic versions of silodosin.
Not addressed in the provided FDA label excerpts.
Generic manufacturers offer silodosin at competitive prices.
Not addressed in the provided FDA label excerpts.
Silodosin relaxes muscles in the prostate and bladder neck.
Mechanism phrased as relaxing muscles in prostate/bladder neck is not explicitly described in provided excerpts; only “selective alpha-1 adrenergic receptor antagonist” is provided.
Relaxing muscles in the prostate and bladder neck helps improve urine flow and reduce BPH symptoms.
Not explicitly stated in the provided excerpts.
Common side effects of silodosin include fainting.
The label excerpt discusses potential for syncope with alpha-blockers (Section 5.1), but “fainting” is not explicitly listed as a common side effect in Section 6.1 provided excerpts; thus not supported as a ‘common side effect’ claim.
Alpha-blockers are commonly used to treat BPH.
Not explicitly stated in provided excerpts.
Other alpha-blockers used to treat BPH include tamsulosin, terazosin, and doxazosin.
Not provided in the supplied FDA label excerpts.
Silodosin and other alpha-blockers can differ in efficacy.
Not provided in the supplied FDA label excerpts.
Silodosin and other alpha-blockers can differ in side effect profiles.
Not provided in the supplied FDA label excerpts.
Silodosin and other alpha-blockers can differ in how they are metabolized by the body.
Not provided in the supplied FDA label excerpts.

Contradictions

Important Omissions

Use in hypertension (not indicated): the response does not mention that RAPAFLO is not indicated for hypertension (Section 1).
Importance: Low
Specific dosing instructions per label (8 mg once daily with a meal; 4 mg for moderate renal impairment; contraindications for severe renal/hepatic impairment; strong CYP3A4 inhibitors contraindicated).
Importance: Moderate
Patient counseling/orthostatic effects safety language (e.g., caution with driving/operating machinery when initiating therapy).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Moderate
The response makes some partially-supported safety claims (dizziness, retrograde ejaculation) but also includes an unsupported ‘fainting’ as a common side effect and omits label-critical contraindications (severe renal/hepatic impairment and strong CYP3A4 inhibitors) and key dosing/renal adjustment details.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Misaligned

Primary Issue
Multiple statements are unrelated to or unsupported by the provided FDA label excerpts (especially pricing/patent/insurance claims and several safety/mechanism claims). Material on-label dosing/contraindication details are omitted.

Suggested Improvement
Restrict claims to label-supported information in Sections 1, 2, 4, 5, 6, and 7; add label-specific dosing (8 mg once daily with a meal; reduce to 4 mg in moderate renal impairment) and contraindications (severe renal impairment, severe hepatic impairment, strong CYP3A4 inhibitors), and align adverse reaction wording to label-listed events.

Drug Brand Mention Assessment

Branding Score
52
Visibility
60
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

primarily prescribed to treat the symptoms of benign prostatic hyperplasia (BPH)

Core Claims
  • Its price varies depending on dosage, quantity, and the pharmacy where it is purchased.
  • A 30-day supply of silodosin 8 mg might range from approximately $225 to over $400 without insurance.
  • Prescription discount cards or coupons can offer savings.
  • Insurance coverage for silodosin can vary by plan, including copayment amounts.
  • Silodosin is available in both brand-name (Rapaflo) and generic forms.
Differentiators
  • It works by relaxing the muscles in the prostate and bladder neck to improve urine flow and reduce BPH symptoms.
  • It is an alpha-blocker used to treat BPH symptoms, with comparable therapeutic goals to other alpha-blockers.
  • Patent expiration is described as a key factor in the availability of more affordable silodosin options.
Pricing Perception: Mid Range
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Tamsulosin 22%
50 #4 No
Terazosin 22%
50 #5 No
Doxazosin 22%
50 #6 No